Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

Finasteride is considered the best treatment for hair loss, despite side effects.

Using finasteride for hair loss or prostate issues does not significantly raise the risk of erectile dysfunction.

Too much prolactin can cause menstrual problems, infertility, and sexual issues in women.

Breast cancer survivors often face body image and sexual health issues, needing ongoing support and open communication with healthcare providers.

The skin's layers protect, sense, and regulate the body's internal balance, but can be prone to cancer.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Dutasteride safely promotes hair growth and reduces hair loss, with mild side effects.

Finasteride has a higher risk of reproductive side effects than minoxidil.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

More hair loss leads to higher risk of psychosexual disorders, especially in women.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Finasteride helps improve hair growth in men with hair loss but may increase the risk of erectile dysfunction.

Post-finasteride Syndrome causes lasting negative effects, but more research is needed for treatment and risk evaluation.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

Finasteride and Dutasteride can improve hair growth in male baldness but may cause temporary sexual dysfunction and possibly affect fertility.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

The conclusion is that doctors should be careful when prescribing 5α-reductase inhibitors due to possible serious side effects, and they should discuss these risks with patients.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Higher DHT levels are linked to fewer hypogonadism symptoms in men with normal testosterone levels.

Finasteride treatment in rats changed the expression of genes related to psychiatric and neurological functions, and these changes persisted after stopping the drug.

Post-finasteride syndrome causes lasting sexual, mental, and physical issues, needing more research for solutions.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

Dermatologists should address erectile dysfunction in patients with skin conditions to improve their quality of life.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.